Renata Karina Reis* and Elizabete Santos Melo
College of Nursing, University of São Paulo, WHO Collaborating Centre for Nursing Research Development Postgraduate Program in Fundamental Nursing Ribeirão Preto SP, Brazil
Received date: September 26, 2015; Accepted date: October 16, 2015; Published date: October 25, 2015
Citation: Reis RK, Melo ES (2015) Cardiovascular Risk in People Living with HIV/ AIDS: Implications for Health Care. J AIDS Clin Res 6:513. doi:10.4172/2155- 6113.1000513
Copyright: © 2015 Reis RK, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Visit for more related articles at Journal of AIDS & Clinical Research
In the past 30 years, medical advances for those with human immunodeficiency virus (HIV) have reduced morbidity and mortality to extend life with the continued development of new therapies . The introduction of Highly Active Antiretroviral Therapy (HAART) has resulted in a more effective infection control, immunity restoration and reduction of morbidity and mortality, transforming AIDS into a chronic disease.
Such advances, however, are now faced with new challenges, among them stand out the need to expand access to ART and improve adherence to this therapy and control the undesirable effects of this therapy, and the need to prevent, recognize and manage emerging comorbidities that in the pre-antiretroviral therapy (HAART), had no great expression .
With this new paradigm, in recent years the cardiovascular risk of people living with HIV/aids has become the focus of researchers studies in different regions and levels of development [3-8]. The presence of other co-morbidities such as hypertension, diabetes, dyslipidemia and obesity, is also common in this population, thereby increasing the risk for developing cardiovascular diseases [9,10] which have emerged as an important cause of morbidity and mortality in adults living with HIV/AIDS .
The traditional paradigm to explain this increased risk includes the effect of HIV infection itself, since they have persistent immune and inflammatory activation, and the effects of antiretroviral therapy, which causes dyslipidemia, ectopic fat accumulation (lipodystrophy) and diabetes or insulin resistance. As well as factors such as smoking, coinfection and drug use. Once such factors contribute to the formation of calcified coronary plaques [7,13].
Thus, the study of Van Vonderen et al. showed that people living with HIV/aids have a higher prevalence and degree of premature coronary atherosclerosis compared to the general population. Similarly, cross-sectional studies have shown that HIV-infected individuals have provided significant risk for acute myocardial infarction (AMI), according to the Framingham scores [7,14].
Taken together, these data suggest a new mechanistic paradigma for atherogenesis in HIV disease, and potential strategies for reducing inflammation and atherosclerosis . These strategies would minimize the classic risk factors such as smoking cessation, blood pressure control, correction of insulin resistance and dyslipidemia, obesity reduction and use of less-toxic antiretroviral therapy. Viral burden and latency can be reduced through earlier initiation of antiretroviral therapy and use of intensification strategies .
Currently, HIV/aids is considered a chronic condition and is associated with increased risk of 50% of acute myocardial infarction in addition to the recognized risk factors  which may have impact on morbidity and mortality of these individuals. By the time discussing the importance of early antiretroviral therapy for people living with HIV/ aids is important not to lose sight of the impact of increased longevity of these individuals in pursuit of development and implementation of public policies to modify a setting that has sociocultural factors which lead to excessive consumption of foods high in calories by population, physical inactivity and, consequently, the development of obesity and diabetes associated with excess dietary salt. These factors contribute to the occurrence of hypertension and are decisive for the high prevalence of CVD .
In addition, the recognition of cardiovascular risk factors among people living with HIV/aids can contribute to the organization of health services in the sense that they have the opportunity to seek interventions aimed at the prevention of CVD through orientation lifestyle changes.
Despite this scenario few studies in Brazil have been conducted to evaluate the risk factors of these individuals.
These indicators point to the need for studies that contribute to the implementation of interventions for the prevention and treatment of cardiovascular risk factors in people living with HIV/aids, as these require interdisciplinary care. In addition, the results may contribute also to structure and strengthen the urgency and emergency care of these individuals in the network of health care.